Merck & Co., Inc. Prezzo — Grafico — Dati Storici
156.43
5.77 (3.83%)
MRK
| %Var. | Settimanale | Mensile | YTD | YoY | |
|---|---|---|---|---|---|
| Merck & Co., Inc. | 3.83% | 11.48% | 14.97% | 41.56% | 76.64% |
Più Recente Merck & Co., Inc. Notizie
Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide use ↗
The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a new avenue of treatment…
Reuters · Aug 25, 12:32 UTC
What Happens if Moderna's Cancer Vaccine Works ↗
Moderna and Merck's personalized cancer vaccine could transform cancer treatment and create a multibillion-dollar market, but investors may already…
Barrons · Aug 25, 10:37 UTC
Nvidia Earnings and Jackson Hole Are the Stock Market's Next Big Tests ↗
Stocks are rallying, but still haven't posted meaningful gains since May. The next three days could change that.
Barrons · Aug 26, 01:00 UTC
China flexes its auto-safety chops with huge recall of Tesla, other cars ↗
A huge recall in China last week aims to address a long-standing fear of EV owners: potentially being trapped in their cars when the power fails. It…
Reuters · Aug 25, 22:42 UTC
Meta, US states have discussed settling teen social media harm case, Bloomberg News reports ↗
Meta Platforms and state attorneys general have discussed a potential mid-trial settlement of a lawsuit accusing the company of deliberately…
Reuters · Aug 25, 21:37 UTC
Intuit Says 75% of Enterprise Customers Deploy AI Agents Monthly ↗
Businesses and accountants are deploying the artificial intelligence-powered tools offered as part of Intuit Intelligence, Intuit Chairman and CEO…
PYMNTS · Aug 25, 20:47 UTC
Correlati
| Correlati | Prezzo | %Var. |
|---|---|---|
| AbbVie Inc. | 265.79 | 0.48% |
| Abbott Laboratories | 116.13 | -0.46% |
| Amgen Inc. | 442.24 | -0.36% |
| Cigna Corporation | 279.32 | -0.40% |
| Danaher Corporation | 215.97 | 0.40% |
| Elevance Health Inc. | 398.87 | -0.93% |
| Eli Lilly and Company | 1,233.5 | -1.08% |
| Gilead Sciences, Inc. | 148.77 | 1.38% |